Diversity, Equity and Inclusivity‐ Low and Middle Income countries and the Lancet commission

Abstract Background Data from high‐income countries (HICs) suggest a decline in age‐specific incidence rates of dementia. However, this has happened primarily in HICs, with low‐ and middle‐ income countries (LMICs) facing two main challenges: a higher burden of risk factors and, in general, a faster ageing population. Most people with dementia live in LMICs, and this is set to increase, thus requiring urgent and robust action to prevent, treat and support people with dementia and their families. Methods We, in the Lancet Commission, reviewed the most recent literature, and conducted a new metanalysis on worldwide dementia risk. We have calculated worldwide figures, although there may be variation in different ethnic and socioeconomic groups. Results Dementia studies are overwhelmingly from HICs, and there is a tendency to recruit people of European origin with higher education and socioeconomic status, with few people from ethnic minority groups. The same applies in respect of worldwide clinical trials, including multicomponent interventions to reduce risk, biomarker research and pharmacological/non‐pharmacological interventions. Although most interventions are developed in HICs, culturally adapted interventions seem to be as effective in LMICs as in their original context, as long as the interventions’ core components are not compromised in the adaptation process. Conclusion Policy interventions can improve dementia prevention, particularly in LMICs and in minority and lower level socio‐economic groups ‐ precisely the people who have the greatest burden of modifiable risk and are more likely to develop dementia. Dementia prevention efforts should be tailored to the needs of the different countries and different groups within countries. Trials and research databases should aim for sociodemographic diversity to reflect real life populations. Although evidence‐based interventions developed in HICs can be effective in LMICs, there is often a lack of healthcare infrastructure and resources to deliver them. Moreover, cultural differences can make them inappropriate or less effective. Interventions should be developed in partnership with local communities to ensure their appropriateness in respect of the culture, beliefs and practises which vary within and between countries.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.085064
Citations
1
Primary Topic
Global Public Health Policies and Epidemiology
Type
article
Field-Weighted Citation Impact
0.67
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diversity, Equity and Inclusivity‐ Low and Middle Income countries and the Lancet commission

Laura N. Gitlin, Suvarna Alladi, Noeline Nakasujja, Kenneth J. Rockwood et al.
1 citations
Alzheimer s & Dementia
Global Public Health Policies and Epidemiology
0.67
article

Diversity, Equity and Inclusivity‐ Low and Middle Income countries and the Lancet commission

Laura N. Gitlin, Suvarna Alladi, Noeline Nakasujja, Kenneth J. Rockwood, Geir Selbæk, Sebastian Walsh, Nick C. Fox, Quincy M. Samus, Alistair Burns, Mika Kivimaki B, Sube Banerjee, Eric B. Larson, Robert Howard, Cleusa P. Ferri, Lon S. Schneider, Archana Singh‐Manoux, Gill Livingston, Jonathan Huntley, Helen C. Kales, Kathy Liu, Andrew Sommerlad, Carol Brayne, Naaheed Mukadam, Sergi Costafreda Gonzalez, Yao Yao, Kokoro Shirai, David Ames
article en
1 citations

Abstract

Abstract Background Data from high‐income countries (HICs) suggest a decline in age‐specific incidence rates of dementia. However, this has happened primarily in HICs, with low‐ and middle‐ income countries (LMICs) facing two main challenges: a higher burden of risk factors and, in general, a faster ageing population. Most people with dementia live in LMICs, and this is set to increase, thus requiring urgent and robust action to prevent, treat and support people with dementia and their families. Methods We, in the Lancet Commission, reviewed the most recent literature, and conducted a new metanalysis on worldwide dementia risk. We have calculated worldwide figures, although there may be variation in different ethnic and socioeconomic groups. Results Dementia studies are overwhelmingly from HICs, and there is a tendency to recruit people of European origin with higher education and socioeconomic status, with few people from ethnic minority groups. The same applies in respect of worldwide clinical trials, including multicomponent interventions to reduce risk, biomarker research and pharmacological/non‐pharmacological interventions. Although most interventions are developed in HICs, culturally adapted interventions seem to be as effective in LMICs as in their original context, as long as the interventions’ core components are not compromised in the adaptation process. Conclusion Policy interventions can improve dementia prevention, particularly in LMICs and in minority and lower level socio‐economic groups ‐ precisely the people who have the greatest burden of modifiable risk and are more likely to develop dementia. Dementia prevention efforts should be tailored to the needs of the different countries and different groups within countries. Trials and research databases should aim for sociodemographic diversity to reflect real life populations. Although evidence‐based interventions developed in HICs can be effective in LMICs, there is often a lack of healthcare infrastructure and resources to deliver them. Moreover, cultural differences can make them inappropriate or less effective. Interventions should be developed in partnership with local communities to ensure their appropriateness in respect of the culture, beliefs and practises which vary within and between countries.

Alzheimer s & DementiaVol. 20(S4)
University of Southern California (US), Oslo University Hospital (NO), University of Nottingham (GB), Johns Hopkins University (US), Inserm (FR), University of Oslo (NO), University of Washington (US), Peking University (CN), Université Paris Cité (FR), University of Exeter (GB), University of Cambridge (GB), Sykehuset i Vestfold (NO), Nova Scotia Health Authority (CA), University of Manchester (GB), National Ageing Research Institute (AU), UK Dementia Research Institute (GB), University College London (GB), National Institute of Mental Health and Neurosciences (IN), Makerere University (UG), Drexel University (US), University of California, Davis (US), Universidade Federal de São Paulo (BR), Camden and Islington NHS Foundation Trust (GB), The University of Osaka (JP)
Openalex Percentile: Top 19%
Global Public Health Policies and Epidemiology
0.67
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.